Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2014
12/10/2014CN104193728A 流感病毒抑制剂及其应用 Influenza virus inhibitors and their applications
12/10/2014CN104193727A 含三氟甲基吡啶的吡唑肟醚类化合物的制备和应用 Preparation and application containing trifluoromethylpyridine pyrazole oxime ether compound
12/10/2014CN104193726A 一种苯甲酸阿格列汀的合成方法 One method of synthesis of alogliptin benzoate
12/10/2014CN104193725A 有机化合物 Organic compounds
12/10/2014CN104193666A 一种1,3-二取代马来酰亚胺化合物及其作为表面活性剂临界胶束浓度荧光探针的应用 One 1,3-substituted maleimide compounds and their use as surfactant critical micelle concentration of fluorescent probes
12/10/2014CN103420976B 伊马替尼及其甲磺酸盐的制备方法 Imatinib mesylate and its preparation method
12/10/2014CN103261185B 连续芳环化合物 Continuous aromatic compounds
12/10/2014CN103214466B 甲基芳基吡唑氟尿嘧啶类化合物、制备方法及应用 Methyl arylpyrazoles fluorouracil compounds, preparation method and application
12/10/2014CN103124730B 杂环炔苯类化合物及其药用组合物和应用 Heterocyclic alkyne benzene compounds and pharmaceutical compositions thereof and applications
12/10/2014CN103087706B 一种单、双光子酸性细胞器荧光探针及其应用 A one, two-photon fluorescence probe acidic organelles and its application
12/10/2014CN103030631B 用于制备嘧啶二酮类dpp-iv抑制剂的化合物 Compound pyrimidine-diones dpp-iv inhibitors for
12/10/2014CN102887889B 杂环取代的嘧啶类化合物 Heterocyclic substituted pyrimidine compounds
12/10/2014CN102887885B 一种埃索美拉唑钠的制备方法 One kind of esomeprazole sodium preparation
12/10/2014CN102812005B β-分泌酶抑制剂 β- secretase inhibitors
12/10/2014CN102574789B 吡咯烷酮甲酰胺衍生物作为趋化素-r(chemr23)调节剂 Pyrrolidone formamide derivatives as chemokine -r (chemr23) modifier
12/10/2014CN102272121B 3-(1-{3-[5-(1-甲基-哌啶-4-基甲氧基)-嘧啶-2-基]-苄基}-6-氧代-1,6-二氢-哒嗪-3-基)-苄腈盐酸盐的多晶型物及其制备方法 3- (1- {3- [5- (1-methyl - piperidin-4-yl-methoxy) - pyrimidin-2-yl] - benzyl} -6-oxo-1,6-dihydro- - pyridazin-3-yl) - benzonitrile hydrochloride polymorph and its preparation method
12/10/2014CN102264723B 作为P2X<sub>7</sub>调节剂的二氢吡啶酮酰胺 As P2X <sub> Dihydropyridones amide 7 </ sub> modifier
12/10/2014CN102203079B 作为激酶抑制剂的吡啶甲酰胺衍生物 As pyridinecarboxamide derivative kinase inhibitors
12/10/2014CN101679239B 组蛋白脱乙酰酶抑制剂 Histone deacetylase inhibitors
12/09/2014US8907101 Sulfonamide derivatives
12/09/2014US8907100 Lansoprazole compound and novel preparation method thereof
12/09/2014US8907099 Nitrocatechol derivatives as COMT inhibitors
12/09/2014US8907097 Pyrido[4,3-b]indoles containing rigid moieties
12/09/2014US8907095 Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119
12/09/2014US8907094 Kinase inhibitors
12/09/2014US8907086 Fused bicyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors
12/09/2014US8906952 Indole derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic diseases containing same as active ingredient
12/09/2014US8906944 Compounds as tyrosine kinase modulators
12/09/2014US8906943 Synthetic compounds and methods to decrease nicotine self-administration
12/09/2014US8906941 Carboxamide compounds and their use as calpain inhibitors
12/09/2014US8906938 C5aR antagonists
12/09/2014US8906937 Flavivirus inhibitors and methods of their use
12/09/2014US8906934 Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors
12/09/2014US8906931 9-[4-(3-chloro-2-fluoro-phenylamino-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5]undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof
12/09/2014US8906930 Quinazoline derivatives
12/09/2014US8906927 Penta-substituted tetrahydropyrimidines with aggregation-induced emission characteristics and preparation method and use thereof
12/09/2014US8906925 Pyrido[4,3-B]indoles containing rigid moieties
12/09/2014US8906924 (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
12/09/2014US8906922 Substituted triazoles useful as AXl inhibitors
12/09/2014US8906918 Compositions, methods of use, and methods of treatment
12/09/2014US8906916 Pyrimidine derivatives as FAK inhibitors
12/09/2014US8906914 Ethylene diamine modulators of fatty acid hydrolase
12/09/2014US8906913 Azabicyclohexanes
12/09/2014US8906904 Alkoxy pyrazoles as soluble guanylate cyclase activators
12/09/2014US8906902 Antibacterial compounds
12/09/2014US8906900 PRMT5 inhibitors and uses thereof
12/09/2014US8906612 Scaffold-based polymerase enzyme substrates
12/09/2014US8906518 Triazole derivative, light-emitting element, light-emitting device, and electronic device
12/04/2014US20140357870 Process for the preparation of dexlansoprazole
12/04/2014US20140357865 Process for the Preparation of Benzoimidazol-2-yl Pyrimidine Derivatives
12/04/2014US20140357858 P2x4 receptor antagonist
12/04/2014US20140357675 Substituted Phenylazole Derivatives
12/04/2014US20140357670 Dihydropyridinone mgat2 inhibitors
12/04/2014US20140357666 Compounds for inhibiting the interaction of bcl2 with binding partners
12/04/2014US20140357653 Chemical compounds
12/04/2014US20140357652 Rho kinase inhibitors
12/04/2014US20140357650 Novel fap inhibitors
12/04/2014US20140357633 Compounds for inhibiting the interaction of bcl2 with binding partners
12/04/2014US20140357632 Benzopiperazine derivatives as cetp inhibitors
12/04/2014US20140357626 Hetero-Bicyclic Derivatives As HCV Inhibitors
12/04/2014US20140357617 Novel heterocyclic acrylamides and their use as pharmaceuticals
12/04/2014US20140357614 Diamino-Pyridine, Pyrimidine, and Pyrazine Modulators of the Histamine H4 Receptor
12/04/2014US20140357613 Aminoheteroaryl compounds and preparation method and use thereof
12/04/2014US20140357599 Novel urea and thiourea derivatives
12/02/2014US8901314 Substituted pyrazoles as N-type calcium channel blockers
12/02/2014US8901313 6,5-heterocyclic propargylic alcohol compounds and uses therefor
12/02/2014US8901308 Triazole compounds that modulate Hsp90 activity
12/02/2014US8901306 Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell
12/02/2014US8901304 Benzo[D]imidazole derivatives of piperidine and piperazine
12/02/2014US8901303 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/02/2014US8901295 Inhibitors of cyclophilins and uses thereof
12/02/2014US8901293 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
12/02/2014US8901153 Pesticidal compositions and processes related thereto
12/02/2014US8901150 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof
12/02/2014US8901148 Large substituent, non-phenolic opioids and methods of use thereof
12/02/2014US8901147 Bi-heteroaryl compounds as Vps34 inhibitors
12/02/2014US8901146 Aminoalkylpyrimidine derivatives as histamine H4 receptor antagonists
12/02/2014US8901143 Pyrimidine derivatives
12/02/2014US8901140 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof
12/02/2014US8901139 Tricyclic indole derivatives and methods of use thereof
12/02/2014US8901138 Sulfoximine substituted quinazolines for pharmaceutical compositions
12/02/2014US8901136 Heteroaryl compounds useful as inhibitors of E1 activating enzymes
12/02/2014US8901133 Heterocyclic compounds and uses thereof
12/02/2014US8901130 Low hygroscopic aripiprazole drug substance and processes for the preparation
12/02/2014US8901124 Pyridazine amide compounds useful as SYK inhibitors
12/02/2014US8901122 Collagen stimulators and their use in the treatment of skin
12/02/2014US8901121 Metalloenzyme inhibitor compounds
12/02/2014US8901120 Substituted N-phenylpyrimidin-2-amine analogs as inhibitors of the Axl kinase
12/02/2014US8901119 Peptide deformylase inhibitors
12/02/2014US8901111 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
12/02/2014US8900785 Charge control agent and toner using the same
12/02/2014US8900728 Carbazole derivative, and light emitting element and light emitting device using the carbazole derivative
12/02/2014US8900566 Hepatitis C virus inhibitors
11/2014
11/27/2014US20140350264 Process for the Preparation of (5-Fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-Acetic Acid Esters
11/27/2014US20140350263 Rapid fluorescence tagging of glycans and other biomolecules with enhanced ms signals
11/27/2014US20140350251 Herbicidal pyrimidines
11/27/2014US20140350250 Therapeutic agent for cerebral infarction
11/27/2014US20140350248 Chemical entities and therapeutic uses thereof
11/27/2014US20140350050 Pyridine compounds as inhibitors of kinase
11/27/2014US20140350037 Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 1080